IP Library Granted Patent US 11,452,860
Granted Patent B2
US 11,452,860 · App. 16/944,564 · Granted Sep 27, 2022

Power source selection for a fully implantable LVAD system

Inventors: Eric A. Schilling (Ham Lake, MN); Jacob A. Roe (North St Paul, MN); Joel B. Artmann (Elk River, MN); Jason C. Lee (Edina, MN); Jonathan P. Roberts (Coon Rapids, MN); David J. Peichel (Minneapolis, MN)
Assignee: Medtronic, Inc.
A61M60/50A61M60/148A61M60/871A61M2205/3365A61M2205/52A61M2205/8206
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,452,860
App. No.
16/944,564
Granted
Sep 27, 2022
Kind
B2
Abstract

A method of managing multiple power sources for an implantable blood pump includes operating the implantable blood pump with both power from an internal battery, the internal battery being disposed within an implantable controller and in communication with the implantable blood pump, and with transcutaneous energy transfer system (TETS) power in communication with the implantable blood pump, if TETS power is available.

Claims (34)

1. A method of managing multiple power sources for an implantable blood pump, comprising:

operating the implantable blood pump with both power from an internal battery and transcutaneous energy transfer system (TETS) power simultaneously, the internal battery being disposed within an implantable controller and in communication with the implantable blood pump, and the TETS in communication with the implantable blood pump.

2. The method of claim 1 , further including subsequently switching the implantable blood pump to operate with only TETS power if:

a set speed of the implantable blood pump is able to be maintained by TETS power alone and an internal battery capacity is greater than a predetermined reserve threshold.

3. The method of claim 1 , further including subsequently switching the implantable blood pump to operate with only TETS power if:

a minimum speed of the implantable blood pump is able to be maintained by TETS power alone and an internal battery capacity is less than a predetermined reserve threshold.

4. The method of claim 1 , further including subsequently switching the implantable blood pump to operate with only TETS power if power from the internal battery is unavailable.

5. The method of claim 1 , further including subsequently switching the implantable blood pump to operate only with power from the internal battery if TETS power is unavailable.

6. The method of claim 1 , further including subsequently switching the implantable blood pump to operate only with power from the internal battery if a battery learning cycle is required and all the prerequisites for the battery learning cycle are met.

7. A method of managing multiple power sources for an implantable blood pump, comprising:

operating the implantable blood pump with both power from an internal battery and transcutaneous energy transfer system (TETS) power simultaneously, the internal battery being disposed within an implantable controller and in communication with the implantable blood pump, and the TETS in communication with the implantable blood pump, if during operation of the implantable blood pump:

a minimum speed of the implantable blood pump is unable to be maintained by TETS power alone and an internal battery capacity is less than a predetermined reserve threshold; or

a set speed of the implantable blood pump is unable to be maintained by TETS power alone and the internal battery capacity is greater than the predetermined reserve threshold.

8. The method of claim 7 , further including subsequently switching the implantable blood pump to operate with only TETS power if power from the internal battery is unavailable.

9. The method of claim 7 , further including subsequently switching the implantable blood pump to operate only with power from the internal battery if TETS power is unavailable.

10. The method of claim 7 , further including subsequently switching the implantable blood pump to operate only with power from the internal battery if a battery learning cycle is required and all the prerequisites for the battery learning cycle are met.

11. A control circuit for an implantable blood pump, comprising:

processing circuitry configured to:

operate the implantable blood pump with both power from an internal battery and transcutaneous energy transfer system (TETS) power simultaneously, the internal battery being disposed within an implantable controller and in communication with the implantable blood pump, and the TETS in communication with the implantable blood pump, if TETS power is available and if battery only operation is not required.

12. The control circuit of claim 11 , wherein the processing circuitry is further configured to subsequently switch the implantable blood pump to operate with only TETS power if:

a set speed of the implantable blood pump is able to be maintained by TETS power alone and an internal battery capacity is greater than a predetermined reserve threshold.

13. The control circuit of claim 11 , wherein the processing circuitry is further configured to subsequently switch the implantable blood pump to operate with only TETS power if:

a minimum speed of the implantable blood pump is able to be maintained by TETS power alone and an internal battery capacity is less than a predetermined reserve threshold.

14. The control circuit of claim 11 , wherein the processing circuitry is further configured to subsequently switch the implantable blood pump to operate only with TETS power if power from the internal battery is unavailable.

15. The control circuit of claim 11 , wherein the processing circuitry is further configured to subsequently switch the implantable blood pump to operate only with power from the internal battery if TETS power is unavailable.

16. The control circuit of claim 11 , wherein the processing circuitry is further configured to subsequently switch the implantable blood pump to operate only with power from the internal battery if a battery learning cycle is required and all the prerequisites for the battery learning cycle are met.

17. A control circuit for an implantable blood pump, comprising:

processing circuitry configured to:

operate the implantable blood pump with both power from an internal battery and transcutaneous energy transfer system (TETS) power simultaneously, the internal battery being disposed within an implantable controller and in communication with the implantable blood pump, and the TETS in communication with the implantable blood pump, if during operation of the implantable blood pump:

a minimum speed of the implantable blood pump is unable to be maintained by TETS power alone and an internal battery capacity is less than a predetermined reserve threshold; or

a set speed of the implantable blood pump is unable to be maintained by TETS power alone and the internal battery capacity is greater than the predetermined reserve threshold.

18. The control circuit of claim 17 , wherein the processing circuitry is further configured to subsequently switch the implantable blood pump to operate with only TETS power if power from the internal battery is unavailable.

19. The control circuit of claim 17 , wherein the processing circuitry is further configured to subsequently switch the implantable blood pump to operate only with power from the internal battery if TETS power is unavailable.

20. The control circuit of claim 17 , wherein the processing circuitry is further configured to subsequently switch the implantable blood pump to operate only with power from the internal battery if a battery learning cycle is required and all the prerequisites for the battery learning cycle are met.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2024
From: MEDTRONIC, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 069492/0072 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 31, 2020
From: SCHILLING, ERIC A.; ROE, JACOB A.; ARTMANN, JOEL B.; LEE, JASON C.; ROBERTS, JONATHAN P.; PEICHEL, DAVID J.
To: MEDTRONIC, INC.
Reel/Frame 053368/0075 →
Continuity (1)
Related Publication 20220031919A1 · Feb 3, 2022